GREY:ATBPF - Post by User
Post by
bringon10baggeron Feb 13, 2021 1:18pm
![](https://assets.stockhouse.com/kentico-cms/0347-00/images/Sprite.svg#id_Post_Views_Icon)
246 Views
Post# 32562069
Global NSAID Sales Growing
Global NSAID Sales GrowingThe global non-steroidal anti-inflammatory drugs (NSAIDs) market is set to gain momentum from the ever-increasing research activities by several prominent pharmaceutical companies on selective cyclooxygenase-2 inhibitors as they are still a grey area for these companies. Tough, NSAIDs such as ibuprofen and diclofenac are nowadays used to hinder the activity of COX, but they have undesirable effect. Fortune Business Insights™ published this information in a new report, titled, “Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further mentions that the NSAIDs market size was USD 15.58 billion in 2019 and is projected to reach USD 24.35 billion by 2027, exhibiting a CAGR of 5.8% during the forecast period.
PICK the Winner...... Fortune Business Insights™ lists out the Key Companies Operating in the NSAIDs Market. They are as follows:
- Pfizer Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Johnson & Johnson Services, Inc.
- Bayer AG
- AstraZeneca
- Zyla Life Sciences
- Horizon Therapeutics plc
- Other key players
What's so refreshing is with these future global sales.....how many $B is big pharma willing to pay for a game changing SAFE NSAID.....time will tell